First Alert 4 continues its work to uncover the solution for the national drug shortage gripping tens of millions of ...

Increasingly, injectable manufacturers recognise that to achieve maximum profitability, they need to focus on the value they ...

An analyst note raising questions about Amgen’s MariTide triggered a stock sell-off Tuesday. Elsewhere, Roche and Novartis ...

Stakeholders in the pharmaceutical industry have warned that the persistent scarcity of essential drugs and subsequent price ...

Dublin, Nov. 05, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering. World revenue for the ...

Drug shortages in the U.S. are increasing in number and duration, primarily affecting generic and multi-sourced drugs that ...

AptarGroup Inc, a firm involved in drug and consumer product dosing ... The facility will help Aptar meet the growing demands ...

Researchers have found a new way to use biocatalysis to improve the production of critical raw materials required for ...

Viking Therapeutics shares climbed 9% on Monday after the drug developer's oral obesity treatment helped reduce body weight ...

The pharmaceutical injectables market is gaining ... laying the foundations for an increase in injectable drugs manufacturing. In the post-pandemic landscape, manufacturers are tapping into ...

High Cost of In-house Drug Development The rising costs associated with in-house drug development and manufacturing are driving significant growth in the pharmaceutical contract manufacturing market.